Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of SIDT2 mRNA | increases expression | 16788091
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SIDT2 mRNA | affects expression | 17562736
|
D001151 |
Arsenic |
Arsenic affects the expression of SIDT2 mRNA | affects expression | 18414638
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SIDT2 mRNA | increases expression | 20382639
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SIDT2 mRNA | affects cotreatment|affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SIDT2 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SIDT2 mRNA | affects cotreatment|affects expression | 17602206
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SIDT2 mRNA | affects cotreatment|increases expression | 17183730
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of SIDT2 mRNA | increases expression | 16249480
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SIDT2 mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of SIDT2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.72 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.94 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.14 | 17162532 19052882 18056438 19061943 17620307 16434500 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.48 | 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.75 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.71 | 17497229 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.91 | 16251483 16835338 18414634 12569548 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.18 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.34 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.86 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.86 | 18316065 18940202 18558336 17688650 17507914 20603192 17157402 19460635 18985861 15238991 19232924 16609825 18396377 18177632 18775368 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.60 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.78 | 16197459 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.51 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.16 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.16 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.83 | 16813970 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.68 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.42 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.78 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
6.78 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.78 | 19335982 16328049 16779866 17138121 19052882 18971187 18785209 19171122 18393292 10737359 3581430 18978308 19107877 17055752 20101231 18665156 20524982 20512989 20007298 19418558 19822196 20727157 17162532 20514400 16807293 19208518 11831363 16830150 19394651 16935385 18056438 16502159 18691550 20214788 18210153 17173139 19701751 16288022 20084675 16698587 18494052 16878318 16681979 18506893 19383236 19919837 21159647 16569478 20432363 17761372 3084413 18788625 17428255 10672840 19519916 17978847 20935162 19539802 16540662 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.78 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.95 | 15504454 17687452 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.95 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.24 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.56 | 19152805 17938729 15738583 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.46 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.54 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.54 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.83 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.83 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.83 | 2727394 21159647 17174075 7505956 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.83 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.76 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.84 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.42 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.73 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.92 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.72 | 8800419 9211117 10589399 9142499 17551590 9664655 16925845 9224671 14991402 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.72 | 16575769 8888407 17688650 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.22 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.48 | 19085960 11739529 11834606 12153990 16485898 11461765 16177239 17906064 12705907 12594235 17522070 19416960 11421492 10774834 16227642 10663392 19923254 18071297 12958197 11743745 15968718 11529661 2444490 14550746 19370779 11287661 16109766 19420014 16781746 18713872 16081117 12540782 14725611 19739265 16393943 15619225 17562736 10915739 14986274 12392966 19164858 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.48 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.48 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.73 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.21 | 16569247 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.38 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.70 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.15 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
14.15 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.15 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.42 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.42 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.82 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.11 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.29 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.42 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.98 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
8.09 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.09 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.78 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.62 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.49 | 9931084 16076760 11953799 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.49 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.84 | 16612254 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.82 | 16093927 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.46 | 18785209 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.98 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.07 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.23 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.10 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.10 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.88 | 12371664 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.84 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.87 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.97 | 19850784 17596541 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.97 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
8.12 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.12 | 17712046 16140955 17339181 16935935 9834237 16788101 19642359 16823087 17649720 19225113 16891316 17301526 17107899 19029980 17217047 16766008 19035177 19075265 17368321 17361223 16331271 15748426 17294898 17506722 12679006 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.43 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.91 | 18665156 20032147 18522880 18407596 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.77 | 12969438 16610002 19460945 19784758 16611625 12587719 19014921 11587558 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.77 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.77 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
7.92 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
7.92 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.92 | 12112319 20492335 20101389 20405173 19254457 9163691 19638242 2422723 19690152 21047994 20452335 19073162 19294768 16942905 19850985 20501860 19996281 19833225 18977376 15885732 21167192 18754104 20434301 20118626 12771043 10737359 20137499 19426721 19499222 18644402 21278145 19256749 19812893 18978307 19642983 19427195 20583210 2862719 19551842 15175105 21071580 19255062 19090486 18648771 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.73 | 21159647 9362446 18253720 18308698 18093689 2563599 19004024 18775883 19126423 19539802 17174075 18544905 18164116 18079962 3124819 18282651 17942915 16267830 19519916 19009564 16842330 17854601 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.53 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.65 | 19168569 17976673 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.65 | 20512841 20970405 6695378 21163286 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.84 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.96 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.64 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.70 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.70 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.12 | 15371236 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.62 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.48 | 16946489 16594593 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.98 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
12.83 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
12.83 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
12.83 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.67 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.67 | 20387270 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.56 | 17056641 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.38 | 20387270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.15 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.15 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.07 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.43 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.43 | 15976015 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.38 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.23 | 15371236 6392382 16905509 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.46 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.46 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.07 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.58 | 16140617 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
9.90 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
9.90 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.03 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.49 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
11.49 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.85 | 17978042 15475178 16876388 3137016 14763951 11738929 1511512 11044598 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.78 | 17453740 16353154 15952646 16759981 17050553 16702368 17938729 19834688 18709164 6392382 17548696 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
6.16 | 16251483 19538983 17050553 15504454 17029826 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.16 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.45 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.45 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.61 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.61 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.95 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.33 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
2.87 | 18640142 19322015 19429237 17976673 15987713 11144890 17306315 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.84 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.88 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.97 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.25 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.12 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |